Influencing future innovators: T3 Labs speaks to the Georgia Tech Masters of Biomedical Innovation and Development class

The Masters of Biomedical Innovation and Development program (BioID program) is a collaborative academic experience in Biomedical technology and a hands-on clinical experience built upon the extraordinary resources and reputation of the Wallace H. Coulter Department of Biomedical Engineering: a joint department of the Georgia Tech College of Engineering and the Emory University School of Medicine.…

Aortic & mitral valves galore plus bioresorbable scaffold results: T3 Labs’ insights from TCT 2016

The Cardiovascular Research Foundation’s annual TCT conference serves as the premier cardiovascular event of the year: delivering the latest clinical and preclinical updates on a wide spectrum of transcatheter therapies and the 2016 edition was no exception. In addition to catching up with existing and prospective sponsors and FDA regulators, here are a few of…

Building bridges and learning about the latest in interventional neurovascular technology at the SVIN 2016

T3 Labs will be present at the Society of Vascular and Interventional Neurology (SVIN) annual meeting, which will be held November 16 – 19, 2016 in Brooklyn, New York. This is a great opportunity to learn about the latest clinical and scientific contributions in endovascular technologies and innovative approaches in the management of stroke and…

Breakthroughs in preventing and treating GI disorders: What we learned at ACG 2016

The American College of Gastroenterology annual conference serves as the premier gastrointestinal event of the year: delivering the latest clinical updates on a wide spectrum of GI disorders and the 2016 edition was no exception. The ACG’s mission is to advance world-class care for patients with gastrointestinal disorders using innovative methods in prevention and treatment.…

Meet us at TCT 2016

Transcatheter Cardiovascular Therapeutics (TCT) is the world’s foremost educational meeting specializing in interventional cardiovascular medicine. This year, TCT 2016 will be hosted October 29th – November 2nd in Washington D.C. The transcatheter cardiovascular innovation space is ever evolving which makes this conference valuable to the T3 Labs team- but we are particularly excited about TCT…

Grab insights on development paths for spine therapy innovation including preclinical testing in the $15 billion global market. Connect onsite with T3 Labs at NASS 2016.

According to Markets and Markets Research, the global market for spinal implants and devices will top $15 billion by 2020. In North America, the gathering with arguably the greatest ability to influence that market, its innovation and growth is the North American Spine Society (NASS) Annual Meeting. T3 Labs’ Orthopaedic and Spine Program Director Dr.…

Meeting the top needs in preclinical cardiology. Understanding the interaction of next generation bioresorbable platforms with underlying vascular tissue.

How T3 Labs helped Abbott Vascular, Dr. Bill Gogas, Dr. Sandeep Kumar, the core teams of Emory University lead by Dr. Habib Samady, and Georgia Tech lead by Dr. Hanjoong Jo, generate and utilize observations from a very long-term translational study toward the understanding of very late vasomotor responses and gene expression profiles in arteries…

Breakthroughs in preventing and treating GI disorders: what to look forward to at ACG 2016

The American College of Gastroenterology annual conference serves as the premier gastrointestinal event of the year: delivering the latest clinical updates on a wide spectrum of GI disorders. The ACG’s mission is to advance world-class care for patients with gastrointestinal disorders using innovative methods in prevention and treatment. As an industry leading preclinical CRO for…

Gearing up to network with cardiothoracic thought leaders in Barcelona at EACTS 2016!

The European Association for Cardio-Thoracic Surgery (EACTS) is holding their annual meeting from October 1-5 in Barcelona, Spain. T3 Labs was originally founded as a cardiovascular research institute, and boasts a decade long track-record in preclinical cardiovascular studies. “The facilities [at T3 Labs] are top tier. They are designed to make it easy to move…